PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
39,023,873
Share change
-1,450,916
Total reported value
$58,153,846
Put/Call ratio
57%
Price per share
$1.49
Number of holders
73
Value change
-$2,416,795
Number of buys
27
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q3 2024

As of 30 Sep 2024, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,023,873 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, Sio Capital Management, LLC, Euclidean Capital LLC, ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, PFM Health Sciences, LP, BML Capital Management, LLC, and BlackRock, Inc.. This page lists 73 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.